cbdMD Shares Outstanding History (YCBD)
cbdMD reported 8.9M shares outstanding at the end of fiscal 2025.
View full cbdMD company overviewcbdMD annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 8.9M | 8.4M | +1711.00% |
| 2024 | 2024-09-30 | 492,383 | −2.5M | −83.37% |
| 2023 | 2023-09-30 | 3.0M | 1.6M | +119.61% |
| 2022 | 2022-09-30 | 1.3M | −56.4M | −97.67% |
| 2021 | 2021-09-30 | 57.8M | 5.7M | +10.84% |
| 2020 | 2020-09-30 | 52.1M | 24.4M | +88.06% |
| 2019 | 2019-09-30 | 27.7M | 19.6M | +241.22% |
| 2018 | 2018-09-30 | 8.1M | 2.3M | +40.25% |
| 2017 | 2017-09-30 | 5.8M | 2.4M | +70.32% |
| 2016 | 2016-09-30 | 3.4M | — | — |
cbdMD quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | 11.1M | 2.2M | +24.81% |
| Q2 2026 | 2026-03-31 | 10.5M | 9.7M | +1239.82% |
| Q1 2026 | 2025-12-31 | 10.1M | 4.5M | +81.68% |
| Q4 2025 | 2025-09-30 | 8.9M | 5.0M | +126.38% |
| Q3 2025 | 2025-06-30 | 8.9M | 5.1M | +136.96% |
| Q2 2025 | 2025-03-31 | 783,355 | −2.3M | −74.28% |
| Q1 2025 | 2024-12-31 | 5.5M | 2.6M | +87.20% |
| Q4 2024 | 2024-09-30 | 3.9M | 978,484 | +33.05% |
| Q3 2024 | 2024-06-30 | 3.8M | 904,203 | +31.67% |
| Q2 2024 | 2024-03-31 | 3.0M | 1.6M | +109.05% |
| Q1 2024 | 2023-12-31 | 3.0M | −57.8M | −95.12% |
| Q4 2023 | 2023-09-30 | 3.0M | −57.7M | −95.12% |
| Q3 2023 | 2023-06-30 | 2.9M | −57.1M | −95.24% |
| Q2 2023 | 2023-03-31 | 1.5M | −57.9M | −97.54% |
| Q1 2023 | 2022-12-31 | 60.7M | 2.4M | +4.18% |
| Q4 2022 | 2022-09-30 | 60.7M | 2.9M | +4.99% |
| Q3 2022 | 2022-06-30 | 59.9M | 3.0M | +5.22% |
| Q2 2022 | 2022-03-31 | 59.3M | 3.0M | +5.30% |
| Q1 2022 | 2021-12-31 | 58.3M | 6.1M | +11.79% |
| Q4 2021 | 2021-09-30 | 57.8M | 5.7M | +10.84% |
| Q3 2021 | 2021-06-30 | 57.0M | 5.6M | +10.96% |
| Q2 2021 | 2021-03-31 | 56.3M | 5.0M | +9.74% |
| Q1 2021 | 2020-12-31 | 52.1M | 24.4M | +88.06% |
| Q4 2020 | 2020-09-30 | 52.1M | 24.4M | +88.06% |
| Q3 2020 | 2020-06-30 | 51.3M | 23.6M | +85.23% |
| Q2 2020 | 2020-03-31 | 51.3M | 41.2M | +404.76% |
| Q1 2020 | 2019-12-31 | 27.7M | 17.6M | +174.59% |
| Q4 2019 | 2019-09-30 | 27.7M | 19.6M | +241.22% |
| Q3 2019 | 2019-06-30 | 27.7M | 19.6M | +241.43% |
| Q2 2019 | 2019-03-31 | 10.2M | 2.1M | +26.59% |
| Q1 2019 | 2018-12-31 | 10.1M | 2.3M | +29.45% |
| Q4 2018 | 2018-09-30 | 8.1M | 2.3M | +40.25% |
| Q3 2018 | 2018-06-30 | 8.1M | 4.7M | +138.73% |
| Q2 2018 | 2018-03-31 | 8.0M | — | — |
| Q1 2018 | 2017-12-31 | 7.8M | — | — |
| Q4 2017 | 2017-09-30 | 5.8M | — | — |
| Q4 2016 | 2016-09-30 | 3.4M | — | — |
cbdMD shares outstanding trends
Over the last five reported fiscal years, cbdMD's shares outstanding moved from 52.1M to 8.9M, a change of −43.2M. The latest reported quarter, Q3 2026, shows 11.1M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review cbdMD filings at SEC.gov ↗